Talkspace (TALK): 2025 Revenue Growth and EBITDA Expansion Boost Outlook

Talkspace Inc. (NASDAQ:TALK) is one of the most promising penny stocks under $5 to buy. On February 19, Talkspace reported 2025 earnings, with total revenue rising 22% year-over-year to ~$229 million. The company showed bottom-line growth, more than doubling its adjusted EBITDA to $15.8 million, while expanding its payer coverage to over 200 million lives. This was driven by a pivot toward enterprise and payer channels, which helped the company reduce marketing expenses even as brand awareness increased through new directory integrations with major insurance partners.

Despite the overall revenue growth, the company experienced a 30.4% decline in consumer-direct revenue, reflecting its deliberate shift away from the individual subscription model. Operating expenses rose by ~10%, influenced by the integration of the Wisdo acquisition. Management also noted the complexities of scaling within the Medicare market, though the company is actively participating in outcome-based CMS programs to capture further growth in Medicare Advantage enrollments.

Dima Sidelnikov/Shutterstock.com

For 2026, Talkspace Inc. (NASDAQ:TALK) is heavily focused on AI and search optimization for LLMs. The company is currently beta testing a specialized AI agent designed for secure mental health support, aiming to differentiate it from general-purpose AI as a clinically backed platform. With plans for further payer integrations in early 2026, the company expects a significant portion of future revenue to be driven by its existing member base and expanded clinical offerings.

Talkspace Inc. (NASDAQ:TALK) operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the US.